OBJECTIVE: A simple method of using fingerstick blood glucose (FSBG) monitors to estimate blood ascorbate values after high-dose intravenous (IV) ascorbate infusion is evaluated as a substitution for high-performance liquid chromatography (HPLC) measurement. METHODS: In 33 participants, readings from FSBG monitors were taken before and after IV ascorbate infusions at various time points, with the postinfusion FSBG readings subtracted from the baseline glucose readings. The results of the subtractions (AAFSBG) were correlated with ascorbate concentrations detected by HPLC (AAHPLC). RESULTS: A linear regression was found between ascorbate concentrations detected by the fingerstick method (AAFSBG) and by HPLC (AAHPLC). The linear correlations were identical in healthy subjects, diabetic subjects, and cancer patients. Analysis of variance obtained an AAFSBG/AAHPLC ratio of 0.90, with a 90% confidence interval of (0.69, 1.20). The corrections of AAFSBG improved similarity to AAHPLC but did not significantly differ from the uncorrected values. CONCLUSION: The FSBG method can be used as an approximate estimation of high blood ascorbate concentration after IV ascorbate (>50 mg/dL, or 2.8 mM) without correction. However, this measurement is not accurate in detecting lower or baseline blood ascorbate. It is also important to highlight that in regard to glucose monitoring, FSBG readings will be erroneously elevated following IV ascorbate use and insulin should not be administered to patients based on these readings.
OBJECTIVE: A simple method of using fingerstick blood glucose (FSBG) monitors to estimate blood ascorbate values after high-dose intravenous (IV) ascorbate infusion is evaluated as a substitution for high-performance liquid chromatography (HPLC) measurement. METHODS: In 33 participants, readings from FSBG monitors were taken before and after IV ascorbate infusions at various time points, with the postinfusion FSBG readings subtracted from the baseline glucose readings. The results of the subtractions (AAFSBG) were correlated with ascorbate concentrations detected by HPLC (AAHPLC). RESULTS: A linear regression was found between ascorbate concentrations detected by the fingerstick method (AAFSBG) and by HPLC (AAHPLC). The linear correlations were identical in healthy subjects, diabetic subjects, and cancerpatients. Analysis of variance obtained an AAFSBG/AAHPLC ratio of 0.90, with a 90% confidence interval of (0.69, 1.20). The corrections of AAFSBG improved similarity to AAHPLC but did not significantly differ from the uncorrected values. CONCLUSION: The FSBG method can be used as an approximate estimation of high blood ascorbate concentration after IV ascorbate (>50 mg/dL, or 2.8 mM) without correction. However, this measurement is not accurate in detecting lower or baseline blood ascorbate. It is also important to highlight that in regard to glucose monitoring, FSBG readings will be erroneously elevated following IV ascorbate use and insulin should not be administered to patients based on these readings.
Authors: Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine Journal: Proc Natl Acad Sci U S A Date: 2005-09-12 Impact factor: 11.205
Authors: Michael J González; Jorge R Miranda-Massari; Edna M Mora; Angelik Guzmán; Neil H Riordan; Hugh D Riordan; Joseph J Casciari; James A Jackson; Angel Román-Franco Journal: Integr Cancer Ther Date: 2005-03 Impact factor: 3.279
Authors: Qi Chen; Michael Graham Espey; Andrew Y Sun; Chaya Pooput; Kenneth L Kirk; Murali C Krishna; Deena Beneda Khosh; Jeanne Drisko; Mark Levine Journal: Proc Natl Acad Sci U S A Date: 2008-08-04 Impact factor: 11.205
Authors: Sebastian J Padayatty; Andrew Y Sun; Qi Chen; Michael Graham Espey; Jeanne Drisko; Mark Levine Journal: PLoS One Date: 2010-07-07 Impact factor: 3.240
Authors: E Ginter; B Zdichynec; O Holzerová; E Tichá; R Kobza; M Koziaková; O Cerná; L Ozdín; F Hrubá; V Nováková; E Sasko; M Gaher Journal: Int J Vitam Nutr Res Date: 1978 Impact factor: 1.784
Authors: L J Hoffer; M Levine; S Assouline; D Melnychuk; S J Padayatty; K Rosadiuk; C Rousseau; L Robitaille; W H Miller Journal: Ann Oncol Date: 2008-06-09 Impact factor: 32.976
Authors: Qi Chen; Michael Graham Espey; Andrew Y Sun; Je-Hyuk Lee; Murali C Krishna; Emily Shacter; Peter L Choyke; Chaya Pooput; Kenneth L Kirk; Garry R Buettner; Mark Levine Journal: Proc Natl Acad Sci U S A Date: 2007-05-14 Impact factor: 11.205
Authors: L John Hoffer; Line Robitaille; Robert Zakarian; David Melnychuk; Petr Kavan; Jason Agulnik; Victor Cohen; David Small; Wilson H Miller Journal: PLoS One Date: 2015-04-07 Impact factor: 3.240
Authors: Jordan R Witmer; Bailey J Wetherell; Brett A Wagner; Juan Du; Joseph J Cullen; Garry R Buettner Journal: Redox Biol Date: 2016-02-13 Impact factor: 11.799
Authors: Heike Niessner; Markus Burkard; Christian Leischner; Olga Renner; Sarah Plöger; Francisco Meraz-Torres; Matti Böcker; Constanze Hirn; Ulrich M Lauer; Sascha Venturelli; Christian Busch; Tobias Sinnberg Journal: Cells Date: 2022-04-05 Impact factor: 6.600
Authors: Anthony J Bazzan; George Zabrecky; Nancy Wintering; Andrew B Newberg; Daniel A Monti Journal: Integr Cancer Ther Date: 2018-05-17 Impact factor: 3.279